Cardiovascular Metabolism and Inflammation Group

Nitric oxide (NO) is a gaseous free radical involved in several homeostatic mechanisms in the body. Our group is interested in the beneficial role of NO in endothelial function and in the maintenance of vascular tone.

We use ozone-based chemiluminescence techniques to make high sensitivity measurements of NO metabolites such as nitrate, nitrite and nitrosothiols in blood and plasma. By profiling these metabolites in patients with different stages of cardiovascular disease, we can test whether oral nitrate supplementation enhances the circulating reservoir of NO metabolites, potentially improving the patient's cardiovascular function.

Extracellular vesicles (EVs) are submicron vesicles released from many cell types as intercellular communicators. EVs contain a bioactive cargo of lipids, proteins and nucleic acids that help to mediate their function and can also be used to identify EVs from complex biofluids.

Our group is interested in the role of EVs in cardiovascular health and disease. We analyse markers carried by EVs circulating in plasma and those from primary adipocyte and endothelial cell cultures to test whether EVs can be used as disease biomarkers for cardiovascular disease and obesity. We also analyse the functional effects of these EVs on endothelial cells, leukocyte populations and isolated vessels. In addition to the biological character of EVs, we are also interested in aiding the standardisation of isolation and detection methods for EV research.

Atherosclerosis plays a major part in the pathogenesis of diseases such as Type 2 Diabetes and its complications (cardiovascular diseases and neuroinflammatory diseases such as stroke). The pathogenesis of atherosclerosis involves a diverse group of cells including macrophages and endothelial cells. Our current interests are in how various lipids and glycosidic flavanoids can influence the inflammatory response through the regulation of macrophage polarization between the inflammatory M1 phenotype and the anti-inflammatory M2 phenotype.  We are also investigating the interaction between endothelial cells and macrophages in angiogenic homeostasis. We measure these responses and interactions by monitoring the secretion of inflammatory mediators such as cytokines and the expression of regulatory transcription factors such as nuclear factor-κB (NF-κB) and the peroxisome proliferator activated receptors (PPARs), in particular PPARγ. We have recently begun to explore the modulation of EV release by saturated and unsaturated lipids and glycosidic flavanoids, and the effects of the resultant EVs on endothelial cells and macrophages.

Disturbances in the flow of blood cells and harmful interactions between blood cells and the blood vessel wall are important in the aetiology and pathophysiology of a range of diseases including cardiovascular disease and diabetes. Our research primarily focuses on how changes in the biochemistry and cytoskeletal function of cells may influence the cells biophysical properties and the flow of blood. We are able to measure the deformability of blood cells by measuring the flow through artificial models of the microcirculation using capillary-sized pores. We have also developed a model to analyse the change in leukocyte flow following alterations to the actin cytoskeleton in diseases such as diabetes. We are currently using these models to explore the role of physical activity and pharmacological intervention in normalising leukocyte biochemistry and biophysics.

Exposure to particulate air pollution and novel engineered nanoparticles presents significant risks to health. Air pollution is the world's largest environmental health risk, with WHO estimating that 7 million people die annually as a result of exposure. The use of novel engineered nanoparticles is increasing, though their potential risks to health and the environment are unclear. Our research investigates the mechanisms by which exposure to air pollution increases cardiovascular risk, for example, by examining the effect of exposure to air pollution particles on leukocyte biochemistry and cytoskeletal function. We have recently begun experiments to monitor the interactions between leukocytes and a range of particulate pollutants, such as diesel exhaust particles and novel engineered particles including silver and iron nanoparticles.